Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 0.77 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.72 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.72 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.72 |
| ▸ | AKT1 | P31749 | 1/20 | 0.72 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.71 |
| ▸ | INPP5A | Q14642 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phytic Acid SCHEMBL9325946 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL9164308 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL141097 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL1682030 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL17006482 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| SCHEMBL8467566 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL1681701 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL9741350 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL15374707 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL12138455 | 1.00 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8054 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130856-A1 | LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF | NANOTECH PHARMA INC (US) | 2026-05-14 | — | — | US | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| CN-122010127-A | Phosphosilicate based bioactive materials and methods of making same | 北京幸福益生再生医学科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260108617-A1 | AUTO-TUNING DRUG REGULATOR CONSTRUCTIONS | RETHINK64 BIONETWORKS PBC (US) | 2026-04-23 | — | — | US | claimed |
| US-20260102414-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | SANIFIT THERAPEUTICS S A (ES) | 2026-04-16 | — | — | US | claimed |
| EP-4719492-A2 | METHODS OF RECOMBINANT ADENO-ASSOCIATED VIRUS KIDNEY ADMINISTRATION | AskBio Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-12594290-B2 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | Sanifit Therapeutics S.A. (ES) | 2026-04-07 | — | — | US | claimed |
| US-20260085281-A1 | Production of Culture Medium through Microbial Co-Hydrolysis of Plant Proteins | BTL HEALTHCARE TECHNOLOGIES AS (CZ) | 2026-03-26 | — | — | US | claimed |
| EP-4284384-B1 | CLINICAL DOSING SCHEDULE OF INS-3001 | VIFOR INT AG (CH) | 2026-03-25 | — | — | EP | claimed |
| US-12582141-B2 | Polypeptides having phytase activity | AB ENZYMES FINLAND OY (FI) | 2026-03-24 | — | — | US | claimed |
| US-4473563-A | LIPOSOMES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1984-09-25 | — | — | US | claimed |
| US-4452747-A | Method of and arrangement for producing lipid vesicles | ERSONDE, KLAUS DR. (DE) | 1984-06-05 | — | — | US | claimed |
| US-4438204-A | Determination of glycosilated hemoglobin | BOEHRINGER MANNHEIM GMBH (DE) | 1984-03-20 | — | — | US | claimed |
| US-4397846-A | Storage-stable lipid vesicles and method of preparation | WEINER MURRAY (US) | 1983-08-09 | — | — | US | claimed |
| EP-0065292-A2 | Process for the storage of unilamellar phospholipid-vesicles | Gersonde, Klaus, Prof. Dr. (DE) | 1982-11-24 | — | — | EP | claimed |
| EP-0052322-A2 | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application | Gersonde, Klaus, Prof. Dr. (DE) | 1982-05-26 | — | — | EP | claimed |
| US-4321259-A | Controlled improvement of the O2 -release by intact erythrocytes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1982-03-23 | — | — | US | claimed |
| EP-0001104-B1 | MODIFIED INTACT ERYTHROCYTES, BLOOD OR BLOOD PRESERVES CONTAINING THEM AND PROCESS FOR THEIR PREPARATION | Studiengesellschaft Kohle mbH (DE) | 1981-05-20 | — | — | EP | claimed |
| US-4255385-A | DIABETES DETECTION | ABBOTT LABORATORIES (US) | 1981-03-10 | — | — | US | claimed |
| US-4192869-A | CONTAINING INOSITOL HEXAPHOSPHATE | STUDIENGESELLSCHAFT KOHLE MBH. (DE) | 1980-03-11 | — | — | US | claimed |